campaign

News

A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co.

News

UCB's Rystiggo can be used by the NHS as a backup treatment for people with the rare autoimmune and neuromuscular disease gMG, says NICE.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.